Rehabilitation in endocrine patients: a novel psychosomatic approach
- PMID: 17917466
- DOI: 10.1159/000107558
Rehabilitation in endocrine patients: a novel psychosomatic approach
Abstract
Long-standing endocrine disorders may imply a degree of irreversibility of the pathological process and induce highly individualized affective responses. The psychosocial impairment that is associated with incomplete remission from endocrine illness suggests the need for an innovative approach to treatment, introducing in clinical endocrinology the concept of rehabilitation, which in other fields of medicine is already established. This new proposal stems from a number of unresolved issues related to the high prevalence of psychosocial impairment in patients adequately treated for various endocrine conditions. Indeed, rehabilitation in endocrinology may be indicated in the following cases: (a) delayed recovery after appropriate treatment; (b) discrepancy between endocrine status and current functioning; (c) presence of a decline in physical and social functioning; (d) persistence of important comorbidity, with special reference to psychiatric disturbances; (e) assessment of abnormal illness behavior; (f) problems with lifestyle and risk behavior, and (g) potential role of stress in endocrine disturbances. The endocrine rehabilitation team should ideally include a trained clinical endocrinologist, a physical therapist and a psychologist, with opportunities for other specialist consultations. The goal of such service would be to ensure education, support and specific interventions, helping the patient and his/her family to achieve optimal coping with the difficulties of the recovery process. Due to its comprehensive psychosomatic characterization, this new approach would likely increase the chances of obtaining full recovery in a significant proportion of patients and has the potential of being cost-effective.
2007 S. Karger AG, Basel
Similar articles
-
Psychosocial impairment in patients treated for pituitary disease: a controlled study.Clin Endocrinol (Oxf). 2007 Nov;67(5):719-26. doi: 10.1111/j.1365-2265.2007.02951.x. Epub 2007 Jul 3. Clin Endocrinol (Oxf). 2007. PMID: 17608817 Clinical Trial.
-
Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors.J Psychosom Res. 2008 Apr;64(4):383-91. doi: 10.1016/j.jpsychores.2007.12.005. J Psychosom Res. 2008. PMID: 18374737
-
[Stress as cardiovascular risk factor].Schweiz Med Wochenschr. 1997 Aug 23;127(34):1391-9. Schweiz Med Wochenschr. 1997. PMID: 9381093 Review. German.
-
[The contribution of social work to psychosomatic rehabilitation in social insurance].Gesundheitswesen. 1994 Aug-Sep;56(8-9):439-43. Gesundheitswesen. 1994. PMID: 8000165 German.
-
Psychosomatic medicine.Int J Clin Pract. 2010 Jul;64(8):1155-61. doi: 10.1111/j.1742-1241.2009.02266.x. Int J Clin Pract. 2010. PMID: 20642714 Review.
Cited by
-
Perception of mental health and professional quality of life in Tunisian doctors during the COVID-19 pandemic: a descriptive cross-sectional study.Pan Afr Med J. 2021 Nov 5;40:139. doi: 10.11604/pamj.2021.40.139.30358. eCollection 2021. Pan Afr Med J. 2021. PMID: 34909107 Free PMC article.
-
The role of interviewing in endocrine practice.J Endocrinol Invest. 2025 Jul;48(7):1539-1548. doi: 10.1007/s40618-025-02565-w. Epub 2025 Mar 29. J Endocrinol Invest. 2025. PMID: 40156708 Free PMC article. Review.
-
Developmental influences on medically unexplained symptoms.Psychother Psychosom. 2009;78(3):139-44. doi: 10.1159/000206866. Epub 2009 Mar 9. Psychother Psychosom. 2009. PMID: 19270468 Free PMC article. Review.
-
Awareness and experience of health-care workers during coronavirus disease 2019 pandemic.J Educ Health Promot. 2021 Mar 31;10:110. doi: 10.4103/jehp.jehp_874_20. eCollection 2021. J Educ Health Promot. 2021. PMID: 34084857 Free PMC article.
-
Problem-solving therapy can reduce psychological distress in patients with Cushing's disease: a randomized controlled trial.Pituitary. 2022 Dec;25(6):891-902. doi: 10.1007/s11102-022-01275-3. Epub 2022 Sep 1. Pituitary. 2022. PMID: 36050587 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical